跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP
Approved
THERAPEUTIC
COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP
PT OTSUKA INDONESIA - INDONESIA REP OFTHAI OTSUKA PHARMACEUTICAL CO LTD (THAILAND)
🇸🇬 Health Sciences Authority
Approval Date
Jun 11, 1991
Approval ID
43514d33a8bc284f
Company
PT OTSUKA INDONESIA - INDONESIA REP OFTHAI OTSUKA PHARMACEUTICAL CO LTD (THAILAND)
Type
Therapeutic
Approval Details
Approval Id
43514d33a8bc284f
Drug Name
COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP
Product Name
COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP
Approval Number
SIN06281P
Approval Date
1991-06-11
Registrant
LUEN WAH MEDICAL COMPANY (SINGAPORE) PRIVATE LIMITED
Licence Holder
LUEN WAH MEDICAL COMPANY (SINGAPORE) PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS
Atc Code
B05XA31
Atc Item Name
electrolytes in combination with other drugs
Pharma Manufacturer Name
LUEN WAH MEDICAL COMPANY (SINGAPORE) PRIVATE LIMITED
Active Ingredients
SODIUM CHLORIDE
0.6 g/100 ml
CALCIUM CHLORIDE
0.027 g/100 ml
LACTIC ACID
0.24 ml/100 ml
POTASSIUM CHLORIDE
0.04 g/100 ml
SODIUM HYDROXIDE
0.115 g/100 ml
CALCIUM CHLORIDE
0.027 g/100 ml
LACTIC ACID
0.24 ml/100 ml
POTASSIUM CHLORIDE
0.04 g/100 ml
SODIUM CHLORIDE
0.6 g/100 ml
SODIUM HYDROXIDE
0.115 g/100 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 11, 1991
Approval ID
43514d33a8bc284f
Type
Therapeutic
Back to HSA Approvals
COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP - HSA Drug Approval Details
